Heron Therapeutics (HRTX) Receives CRL for HTX-011 for Management of Postoperative Pain
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/19/2026
- Nasdaq climbs over 1% as AI-linked stocks recover ahead of key earnings
- U.S. economy is "booming," JPMorgan’s Dimon says
- Musk pledges one share of SpaceX to every U.S. child
- Oil edges higher as investors weigh renewed Houthi attacks on Saudi infrastructure
- Prepare to buy the dip as U.S. stock selloff nears its end: Morgan Stanley
| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.35 -0.01 (2.78%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $31.32 | |||
| Open | $0.36 | 52 Week Low | $13.95 | |||
| Day High | $0.38 | P/E | N/A | |||
| Day Low | $0.35 | EPS | $-3.29 | |||
| Volume | 1,113,972 | |||||
